Literature DB >> 9828213

Differential expression and regulation of nucleoside transport systems in rat liver parenchymal and hepatoma cells.

B del Santo1, R Valdés, J Mata, A Felipe, F J Casado, M Pastor-Anglada.   

Abstract

Primary cultures of rat-liver parenchymal cells show carrier-mediated nucleoside uptake by a mechanism that mainly involves concentrative, Na+-dependent transport activity. In contrast, the hepatoma cell line FAO shows high nucleoside transport activity, although it is mostly accounted for by Na+-independent transport processes. This is associated with a low amount of sodium purine nucleoside transporter (SPNT) mRNA. SPNT encodes a purine-preferring transporter expressed in liver parenchymal cells. To analyze whether SPNT expression is modulated during cell proliferation, SPNT mRNA levels were determined in the early phase of liver growth after partial hepatectomy and in synchronized FAO cells that had been induced to proliferate. SPNT mRNA amounts increased as early as 2 hours after partial hepatectomy. FAO cells induced to proliferate after serum refeeding show an increase in SPNT mRNA levels, which is followed by an increase in Na+-dependent nucleoside uptake and occurs before the peak of 3H-thymidine incorporation into DNA. FAO cells also express significant equilibrative nucleoside transport activity, which may be accounted for by the expression of the nitrobenzylthioinosine (NBTI)-sensitive and -insensitive isoforms, rat equilibrative nucleoside transporter 1 (rENT1) and rENT2, respectively. Interestingly, rENT2 mRNA levels follow a similar pattern to that described for SPNT when FAO cells are induced to proliferate, whereas rENT1 appears to be constitutively expressed. Liver parenchymal cells show low and negligible mRNA levels for rENT1 and rENT2 transporters, respectively, although most of the equilibrative transport activity found in hepatocytes is NBTI-resistant. It is concluded that: 1) SPNT expression is regulated both in vivo and in vitro in a way that appears to be dependent on cell cycle progression; 2) SPNT expression may be a feature of differentiated hepatocytes; and 3) equilibrative transporters are differentially regulated, rENT2 expression being cell cycle-dependent. This is consistent with its putative role as a growth factor-induced delayed early response gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9828213     DOI: 10.1002/hep.510280609

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

Review 1.  Nucleoside transporters in absorptive epithelia.

Authors:  F J Casado; M P Lostao; I Aymerich; I M Larráyoz; S Duflot; S Rodríguez-Mulero; M Pastor-Anglada
Journal:  J Physiol Biochem       Date:  2002-12       Impact factor: 4.158

2.  ATP-sensitive K(+) channels regulate the concentrative adenosine transporter CNT2 following activation by A(1) adenosine receptors.

Authors:  Sylvie Duflot; Bárbara Riera; Sonia Fernández-Veledo; Vicent Casadó; Robert I Norman; F Javier Casado; Carme Lluís; Rafael Franco; Marçal Pastor-Anglada
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

3.  Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells.

Authors:  David A Plotnik; Lindsay E Emerick; Kenneth A Krohn; Jashvant D Unadkat; Jeffrey L Schwartz
Journal:  J Nucl Med       Date:  2010-08-18       Impact factor: 10.057

4.  Bile acids alter the subcellular localization of CNT2 (concentrative nucleoside cotransporter) and increase CNT2-related transport activity in liver parenchymal cells.

Authors:  Sonia Fernández-Veledo; Isabel Huber-Ruano; Ivette Aymerich; Sylvie Duflot; F Javier Casado; Marçal Pastor-Anglada
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

5.  The role of nucleoside/nucleotide transport and metabolism in the uptake and retention of 3'-fluoro-3'-deoxythymidine in human B-lymphoblast cells.

Authors:  David A Plotnik; Lena J McLaughlin; Jenny Chan; Joshua N Redmayne-Titley; Jeffrey L Schwartz
Journal:  Nucl Med Biol       Date:  2011-06-22       Impact factor: 2.408

6.  Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells.

Authors:  C Arimany-Nardi; A Montraveta; E Lee-Vergés; X S Puente; H Koepsell; E Campo; D Colomer; M Pastor-Anglada
Journal:  Pharmacogenomics J       Date:  2015-01-13       Impact factor: 3.550

7.  Striking species difference in the contribution of concentrative nucleoside transporter 2 to nucleoside uptake between mouse and rat hepatocytes.

Authors:  Tomomi Furihata; Yukina Fukuchi; Minami Iikura; Misato Hashizume; Atsushi Miyajima; Miki Nagai; Kan Chiba
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

8.  Interferon-gamma regulates nucleoside transport systems in macrophages through signal transduction and activator of transduction factor 1 (STAT1)-dependent and -independent signalling pathways.

Authors:  Concepció Soler; Antonio Felipe; José García-Manteiga; Maria Serra; Elena Guillén-Gómez; F Javier Casado; Carol MacLeod; Manuel Modolell; Marçal Pastor-Anglada; Antonio Celada
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

9.  Functional differences in nucleoside and nucleobase transporters expressed on the rabbit corneal epithelial cell line (SIRC) and isolated rabbit cornea.

Authors:  Soumyajit Majumdar; Giridhar S Tirucherai; Dhananjay Pal; Ashim K Mitra
Journal:  AAPS PharmSci       Date:  2003

Review 10.  The concentrative nucleoside transporter family, SLC28.

Authors:  Jennifer H Gray; Ryan P Owen; Kathleen M Giacomini
Journal:  Pflugers Arch       Date:  2003-07-11       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.